Immunovia AB (publ)

IMMVF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$109,411-$309,439-$191,150-$166,628
Dep. & Amort.$0$141,719$24,913$19,063
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$6,140$7,134-$7,154-$5,338
Other Non-Cash$18,798$13,529-$2,191$255
Operating Cash Flow-$96,753-$147,057-$175,582-$152,648
Investing Activities
PP&E Inv.$0-$1,061-$1,624-$24,184
Net Acquisitions$0$0$0$39
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$4,258-$368$319
Investing Cash Flow$0$3,197-$1,624-$23,826
Financing Activities
Debt Repay.-$7,599$0$0$0
Stock Issued$52,411$121,243$639$440
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$6,500-$5,746-$5,709
Financing Cash Flow$44,812$114,743-$5,107-$5,269
Forex Effect$471-$136$948$687
Net Chg. in Cash-$51,470-$29,253-$181,365-$181,056
Supplemental Information
Beg. Cash$76,788$106,041$287,406$468,462
End Cash$25,318$76,788$106,041$287,406
Free Cash Flow-$96,753-$148,118-$177,206-$176,832
Immunovia AB (publ) (IMMVF) Financial Statements & Key Stats | AlphaPilot